CClinicalTrials.gg
CompletedNCT05425706Updated Jun 21, 2022

Sustained Natural Apophysial Glides (SNAGs) Technique in Non-Specific Neck Pain Patients

An interventional study of application of SNAGs technique in Neck Pain, sponsored by Hacettepe University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2022-06-21.

Sponsored by Hacettepe University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 1 month after the study started (first participant enrolled Apr 2019, registered Jun 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Mechanical neck pain is defined for the absence of cervical spinal pathologies.With the SNAGs mobile mobilization method, it reveals effective results in cases of limitation and pain in the cervical joints.Although there are studies with the Mulligan concept in the literature, studies examining the effects of the SNAGs technique on non-specific neck pain are limited.

The aim of this study is to investigate the effectiveness of the Mulligan Concept SNAGs mobilization method applied in addition to the conventional physiotherapy program in individuals with nonspecific neck pain.

Read the detailed description

This study was conducted to investigate the effectiveness of Mulligan concept cervical sustained natural apophysial glides (SNAGs) mobilization method in addition to the conventional treatment program in patients with nonspecific neck pain. The study included 40 patients (18-50 years of age) with non-specific neck pain, radicular compression and loss of strength for at least 3 months, diagnosed by a specialist physician; patients with central nervous system disease, distal-peripheral nerve injuries Patients with inflammatory joint disease, cervical spine fracture or surgery, patients with upper extremity surgery, cervical spine tumor and infection, cervical spine congenital anomaly and diabetes were not included in the study. 15 sessions were applied for 3 weeks, 5 days a week for 10 weeks, 10 minutes ultrasound, 20 minutes transcutaneous electrical nerve stimulation (TENS) and hotpack application and Mulligan mobilization in addition to physiotherapy programs. The patient was rested for 5 seconds between sets. The physiotherapy program was applied to the control group and the application session was completed. Normal range of motion exercises were performed in both groups and given as home exercise.

02

Conditions studied

  • Neck Pain

Browse trials for

Keywords

  • manual therapy
  • neck pain
  • SNAGs
  • sleep quality
  • quality of life
03

In context

Neck Pain

1,232 studies on the registry are indexed under Neck Pain; 255 are open to participants now.

This study's enrollment of 32 is below the median of 52 across 1,004 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

Hacettepe University is the lead sponsor of 983 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Volunteer patients with non-specific neck pain lasting at least 3 months,
  • Volunteer patients without radicular pressure,
  • Volunteer patients with loss of strength,
  • Volunteer patients diagnosed with non-specific neck pain by a specialist physician.

Exclusion criteria

Exclusion Criteria:

  • Volunteer patients with central nervous system disease,
  • Volunteer patients with distal-peripheral nerve injuries,
  • Volunteer patients with inflammatory joint disease,
  • Volunteer patients with cervical spine fracture or surgery, upper extremity surgery,
  • Volunteer patients with vertebrobasilar artery stenosis,
  • Volunteer patients with osteoporosis,
  • Volunteer patients with cervical dislocation,
  • Volunteer patients with cervical spine tumor and infection,
  • Volunteer patients with congenital anomalies involving the spine,
  • Volunteer patients with patients with diabetes.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    experiment group

    Number of participant is 16. In addition to the conventional therapy, SNAGs technique was applied.

    Other: application of SNAGs technique

  • No intervention
    control group

    Number of participant is 16. Only the conventional therapy was applied.

Interventions

  • Otherapplication of SNAGs technique

    in experiment group, the SNAGs technique was applied to 16 participants in addition to conventional therapy.

06

What researchers measure

Primary outcomes

  1. Range of motion assessments

    Active and passive range of motion

    Time frame: Two weeks for each participants

  2. Pain assessments

    McGill Pain Scale; minimum pain score: 0, maximum pain score: 78, The higher the pain score the greater the pain.

    Time frame: Two weeks for each participants

Secondary outcomes

  1. Sleep quality assessments

    Pittsburgh Sleep Quality Index (PSQI)

    Time frame: Two weeks for each participants

  2. Quality of life assessments

    The Nottingham Health Profile

    Time frame: Two weeks for each participants

07

Study locations

1 site
  • Istınye University Medical Park Hospital
    Istanbul, Turkey
08

References and documents

Publications

  • Ali A, Shakil-Ur-Rehman S, Sibtain F. The efficacy of Sustained Natural Apophyseal Glides with and without Isometric Exercise Training in Non-specific Neck Pain. Pak J Med Sci. 2014 Jul;30(4):872-4. PubMed 25097535 ↗
  • Shin EJ, Lee BH. The effect of sustained natural apophyseal glides on headache, duration and cervical function in women with cervicogenic headache. J Exerc Rehabil. 2014 Apr 30;10(2):131-5. doi: 10.12965/jer.140098. eCollection 2014 Apr. PubMed 24877050 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05425706
Lead sponsor
Hacettepe University
Responsible party
Duygu Korkem (Assistant Professor, Hacettepe University) — Principal investigator
First posted
Jun 21, 2022
Start date
Apr 22, 2019
Primary completion
Jan 6, 2020
Completion
Apr 6, 2020
Last update
Jun 21, 2022

Study contacts

DUYGU KORKEM YORULMAZ, PhD.
principal investigator · ISTINYE UNİVERSITY

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion